IGF::OT::IGF TASK ORDER TITLE:CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER)PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2016

IGF::OT::IGF 任务订单标题：监测、流行病学和最终结果 (SEER) 的核心基础设施支持 执行期间：2015 年 5 月 1 日至 2016 年 4 月 30 日

• 批准号: 9067067
• 负责人: DENNIS DEAPEN
• 金额: $ 348万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-05-01 至 2016-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9067067
• 关键词: Cancer Burden; Cancer Control; Cancer Etiology; Cancer Patient; Colorectal Cancer; Diagnosis; Disease; Incidence; Malignant Neoplasms; Malignant neoplasm of lung; Malignant neoplasm of pancreas; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Medical Surveillance; Monitor; National Cancer Institute; National Cancer Program; Patients; Performance; Population; Reporting; Research Infrastructure; Resources; SEER Program; Social Characteristics; Subgroup; Time; Treatment-Related Cancer; United States; base; cancer risk; cancer site; cancer therapy; malignant breast neoplasm; operation; response; trend

The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. The SEER Program has among its objectives: 1. To assemble and report, on a periodic basis, estimates of cancer incidence, especially among the following key cancer sites: breast cancer, lung cancer, colorectal cancer, prostate cancer, pancreatic cancer, and urinary bladder cancer. 2. To monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. 3. To provide continuing information on changes over time in extent of disease at diagnosis, trends in therapy, and changes in cancer patient survival. 4. To identify the occurrence of possible iatrogenic cancers, i.e., cancers that are caused by cancer therapy. 5. To serve as a research resource to the National Cancer Institute, and conduct studies dealing with current cancer control issues as well as problems related to the operation of the SEER Program.

SEER计划于1972年启动，以应对国家癌症计划的要求，以评估美国癌症负担的大小，并确定与癌症风险和/或患者生存有关的因素。 SEER计划具有其目标： 1。要定期组装和报告癌症发病率的估计，尤其是在以下关键癌症部位：乳腺癌，肺癌，结直肠癌，前列腺癌，胰腺癌和膀胱癌。 2。监测年度癌症发病率趋势，以确定由地理，人口统计学和社会特征定义的人群亚组发生的特定癌症的异常变化。 3。提供有关随着时间的变化的持续信息，诊断趋势，治疗趋势以​​及癌症患者生存的变化。 4。确定可能的医源性癌症的发生，即是由癌症治疗引起的癌症。 5。作为国家癌症研究所的研究资源，并进行有关当前癌症控制问题的研究以及与SEER计划有关的问题。